SNDX Syndax Pharmaceuticals, Inc.

Fundamentals / CIK 0001395937 / USD

Syndax Pharmaceuticals, Inc. reported $289.7M in revenue and a net loss of $209.5M for the trailing twelve months ended September 30, 2026 (up 81.6% year over year), with a -61.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SNDX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$203.5M$101.8M$0-$312.7MFY 2016 Revenue: $1.22MFY 2016 Net Income: -$44.47M2016FY 2017 Revenue: $2.11MFY 2017 Net Income: -$60.80M2017FY 2018 Revenue: $1.52MFY 2018 Net Income: -$73.96M2018FY 2019 Revenue: $1.52MFY 2019 Net Income: -$56.05M2019FY 2020 Revenue: $1.52MFY 2020 Net Income: -$73.16M2020FY 2021 Revenue: $139.7MFY 2021 Net Income: $24.93M2021FY 2022 Revenue: $0FY 2022 Net Income: -$149.3M2022FY 2023 Revenue: $0FY 2023 Net Income: -$209.4M2023FY 2024 Revenue: $23.68MFY 2024 Net Income: -$318.8M2024FY 2025 Revenue: $172.4MFY 2025 Net Income: -$285.4M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $172.4M $23.68M $0 $0 $139.7M $1.52M $1.52M $1.52M $2.11M $1.22M
Research & Development $258.8M $241.6M $163.0M $118.5M $88.25M $50.44M $42.99M $60.11M $48.20M $31.66M
Selling, General & Admin $179.7M $120.9M $66.92M $33.26M $25.24M -- -- -- -- --
Total Operating Expenses $445.4M $363.4M $230.0M $151.8M $113.5M $72.94M $59.06M $77.39M $64.06M $44.99M
Operating Income -$273.1M -$339.7M -$230.0M -$151.8M $26.22M -$71.42M -$57.54M -$75.88M -$61.95M -$43.77M
EBITDA -$267.1M -$331.7M -$218.0M -$118.8M $69.22M -$71.33M -$57.45M -$75.80M -$61.88M -$43.68M
Interest Income $22.73M $26.09M $21.16M $5.87M $403K $841K $1.57M $1.94M -- --
Interest Expense $6.0K -$1.0K $208K $3.14M $1.90M $2.36M -- -- -- --
Income Tax Expense $433K -- -- -- $0 $0 $0 $0 $0 $0
Net Income -$285.4M -$318.8M -$209.4M -$149.3M $24.93M -$73.16M -$56.05M -$73.96M -$60.80M -$44.47M
Basic EPS -$3.29 -$3.72 -$2.98 -$2.46 $0.48 -$1.87 -$1.84 -$2.92 -$2.90 -$3.22
Diluted EPS -$3.29 -$3.72 -$2.98 -$2.46 $0.46 -$1.87 -$1.84 -$2.92 -$2.90 -$3.22
Basic Shares Outstanding 86.6M 85.6M 70.4M 60.8M 52.1M 41.3M 30.5M 25.4M 21.0M 14.6M
Diluted Shares Outstanding 86.6M 85.6M 70.4M 60.8M 53.6M 41.3M 30.5M 25.4M 21.0M 14.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $83.30M $72.79M $64.86M $68.73M $45.87M $37.96M $20.04M $7.68M
Research & Development $67.48M $68.04M $58.84M $78.64M $56.28M $62.23M $61.64M $65.53M
Total Operating Expenses $125.2M $112.8M $99.07M $131.3M $103.3M $107.3M $103.8M $104.0M
Operating Income -$41.90M -$39.99M -$34.20M -$62.55M -$57.43M -$69.35M -$83.76M -$96.36M
EBITDA -$35.90M -$34.99M -$30.20M -$59.55M -$54.43M -$69.35M -$83.76M --
Interest Income $5.59M $3.75M $3.56M $4.33M $5.27M $5.95M $7.18M $7.11M
Interest Expense $2.0K $2.0K $0 $0 $0 $4.0K $2.0K -$124K
Income Tax Expense $0 $0 $0 $433K $0 $0 $0 --
Net Income -$49.43M -$49.36M -$42.67M -$68.01M -$60.72M -$71.85M -$84.85M -$94.17M
Basic EPS -$0.55 -$0.55 -$0.48 -- -$0.70 -$0.83 -$0.98 --
Diluted EPS -$0.55 -$0.55 -$0.48 -- -$0.70 -$0.83 -$0.98 --
Basic Shares Outstanding 89.8M 89.0M 88.3M -- 86.6M 86.3M 86.2M --
Diluted Shares Outstanding 89.8M 89.0M 88.3M -- 86.6M 86.3M 86.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $134.9M $154.1M $295.4M $74.36M $222.0M $115.2M $24.61M $33.77M $35.17M $23.84M
Short-Term Investments $259.1M $418.8M $275.3M $401.4M $218.0M $177.8M $35.17M $47.14M $94.81M $81.49M
Cash & Short-Term Investments $394.1M $572.9M $570.7M $475.8M $439.9M $293.1M $59.77M $80.91M $130.0M $105.3M
Accounts Receivable, Net $38.00M $7.60M $0 -- -- -- -- -- -- --
Inventory $32.75M $366K $0 -- -- -- -- -- -- --
Other Current Assets -- -- $0 -- -- -- -- -- -- --
Total Current Assets $528.1M $603.1M $580.9M $489.8M $448.4M $298.9M $62.33M $83.35M $133.4M $108.5M
Property, Plant & Equipment, Net $181K $0 $8.0K $20K $278K $192K $281K $373K $267K $260K
Long-Term Investments $0 $119.5M $29.83M $5.47M $0 -- -- -- $3.25M --
Other Non-Current Assets -- $0 $463K $807K $0 $1.27M $197K $219K $231K $243K
Total Non-Current Assets $1.62M $121.8M $32.00M $7.45M $1.26M $1.75M $1.19M $592K $3.74M $503K
Total Assets $529.7M $724.8M $612.9M $497.2M $449.7M $300.6M $63.52M $83.94M $137.2M $109.0M
Accounts Payable $16.58M $11.63M $9.96M $4.35M $5.67M $3.51M $6.18M $1.44M $2.23M $2.38M
Short-Term Debt $343.9M $343.7M $0 -- -- -- -- -- -- --
Deferred Revenue (Current) -- -- -- -- -- $1.52M $1.52M $1.52M $1.57M $1.22M
Total Current Liabilities $120.1M $103.5M $58.10M $29.07M $20.68M $18.87M $18.37M $16.11M $15.80M $10.37M
Deferred Revenue (Non-Current) -- -- -- -- -- $11.62M $13.13M $14.65M $16.76M $14.22M
Other Non-Current Liabilities -- -- -- -- -- $1.0K $5.0K $136K $310K $288K
Total Non-Current Liabilities $345.0M $333.1M $588K $722K $20.61M $29.55M $13.56M $14.79M $17.07M $14.51M
Total Liabilities $465.1M $436.7M $58.68M $29.79M $41.29M $48.42M $31.93M $30.89M $32.87M $24.87M
Total Debt (incl. Leases) $345.4M $345.7M $1.61M $1.14M $1.07M $417K $897K -- -- --
Common Stock $9.0K $9.0K $8.0K $7.0K $6.0K $5.0K $3.0K $2.0K $2.0K $2.0K
Retained Earnings -$1.51B -$1.22B -$902.4M -$693.0M -$543.7M -$568.6M -$495.5M -$439.4M -$366.1M -$305.3M
Total Stockholders' Equity $64.63M $288.1M $554.2M $467.4M $408.4M $252.2M $31.60M $53.05M $104.3M $84.14M
Total Equity $64.63M $288.1M $554.2M $467.4M $408.4M $252.2M $31.60M $53.05M $104.3M $84.14M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $135.9M $336.5M $130.9M $134.9M $116.8M $108.6M $154.0M $154.1M
Short-Term Investments $291.2M $211.4M $221.2M $259.1M $319.2M $346.6M $358.2M $418.8M
Cash & Short-Term Investments $427.1M $547.9M $352.1M $394.1M $436.0M $455.2M $512.2M $572.9M
Accounts Receivable, Net -- -- -- $38.00M -- -- -- $7.60M
Inventory $39.38M $33.16M $34.95M $32.75M $25.00M $17.70M $4.66M $366K
Total Current Assets $567.4M $675.0M $471.2M $528.1M $529.8M $531.7M $548.8M $603.1M
Property, Plant & Equipment, Net $206K $212K $177K $181K $128K $0 $0 $0
Long-Term Investments $124.0M $27.22M -- $0 $20.15M $62.63M $89.94M $119.5M
Other Non-Current Assets -- -- -- -- -- -- -- $0
Total Non-Current Assets $125.2M $28.61M $1.49M $1.62M $21.96M $64.47M $91.96M $121.8M
Total Assets $692.7M $703.7M $472.7M $529.7M $551.8M $596.1M $640.7M $724.8M
Accounts Payable $3.57M $4.87M $10.84M $16.58M $13.83M $17.35M $10.05M $11.63M
Short-Term Debt $344.1M $344.0M $344.0M $343.9M $343.9M $343.8M $343.8M $343.7M
Total Current Liabilities $121.0M $99.68M $86.17M $120.1M $114.2M $113.0M $94.55M $103.5M
Total Non-Current Liabilities $588.9M $588.9M $344.9M $345.0M $322.2M $325.7M $331.1M $333.1M
Total Liabilities $709.9M $688.6M $431.0M $465.1M $436.4M $438.7M $425.6M $436.7M
Total Debt (incl. Leases) $344.6M $344.5M $344.5M $345.4M $344.2M $344.2M $344.2M $345.7M
Common Stock $9.0K $9.0K $9.0K $9.0K $9.0K $9.0K $9.0K $9.0K
Retained Earnings -$1.65B -$1.60B -$1.55B -$1.51B -$1.44B -$1.38B -$1.31B -$1.22B
Total Stockholders' Equity -$17.18M $15.10M $41.62M $64.63M $115.4M $157.4M $215.1M $288.1M
Total Equity -$17.18M $15.10M $41.62M $64.63M $115.4M $157.4M $215.1M $288.1M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$285.4M -$318.8M -$209.4M -$149.3M $24.93M -$73.16M -$56.05M -$73.96M -$60.80M -$44.47M
Depreciation & Amortization $6.00M $8.00M $12.00M $33.00M $43.00M $90K $92K $78K $76K $89K
Stock-Based Compensation $47.50M $43.03M $30.95M $16.02M $13.32M $9.06M $6.00M $6.20M $5.45M $4.71M
Change in Receivables -$30.39M -$7.60M $0 $0 -- -- -- -- -- --
Change in Inventory -$32.09M -$366K $0 $0 -- -- -- -- -- --
Change in Payables $4.95M $1.67M $5.61M -$1.32M $2.16M -$2.67M $4.74M -$792K -$194K $923K
Operating Cash Flow -$323.0M -$274.9M -$160.6M -$133.7M $29.13M -$71.26M -$50.61M -$68.53M -$47.37M -$35.16M
Capital Expenditure -$187K $0 $0 $0 -$129K $0 -- -$187K -$84K -$261K
Free Cash Flow -$323.2M -$274.9M -$160.6M -$133.7M $29.00M -$71.26M -- -$68.72M -$47.45M -$35.42M
Investing Cash Flow $290.0M -$219.8M $117.6M -$186.2M -$40.87M -$142.5M $12.78M $51.40M -$17.07M -$18.28M
Financing Cash Flow $13.68M $353.4M $264.1M $172.3M $118.5M $304.4M $28.57M $15.73M $75.72M $54.20M
Net Change in Cash -$19.27M -$141.3M $221.1M -$147.6M $106.7M $90.63M -$9.26M -$1.40M $11.28M $762K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$49.43M -$49.36M -$42.67M -$68.01M -$60.72M -$71.85M -$84.85M -$94.17M
Depreciation & Amortization $6.00M $5.00M $4.00M $3.00M $3.00M $0 $0 --
Stock-Based Compensation $15.29M $14.01M $12.05M $11.25M $12.08M $13.79M $10.38M $12.30M
Change in Receivables -$1.80M -$7.19M $120K -$12.59M -$5.95M -$3.73M -$8.12M -$7.60M
Change in Inventory -$6.02M $1.84M -$2.06M -$7.80M -$7.18M -$12.92M -$4.19M -$366K
Change in Payables -$1.30M -$5.97M -$5.74M $2.75M -$3.53M $7.31M -$1.58M $6.73M
Operating Cash Flow -$27.25M -$30.27M -$50.34M -$69.49M -$70.53M -$87.80M -$95.16M -$57.39M
Investing Cash Flow -$176.5M -$16.91M $38.39M $81.58M $72.43M $41.89M $94.14M -$269.0M
Financing Cash Flow $3.19M $252.8M $7.92M $5.92M $6.28M $551K $930K $347.4M
Net Change in Cash -$200.5M $205.6M -$4.04M $18.01M $8.17M -$45.36M -$90K $21.06M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -158.4% -1434.4% -- -- 18.8% -4708.2% -3792.9% -5001.7% -2939.0% -3587.4%
Net Profit Margin -165.6% -1346.1% -- -- 17.8% -4822.5% -3694.6% -4875.5% -2884.3% -3645.2%
Return on Equity (ROE) -441.6% -110.6% -37.8% -31.9% 6.1% -29.0% -177.4% -139.4% -58.3% -52.9%
Return on Assets (ROA) -53.9% -44.0% -34.2% -30.0% 5.5% -24.3% -88.2% -88.1% -44.3% -40.8%
Current Ratio 4.40x 5.82x 10.00x 16.85x 21.68x 15.84x 3.39x 5.18x 8.45x 10.47x
Quick Ratio 4.12x 5.82x 10.00x 16.37x 21.27x 15.53x 3.25x 5.02x 8.23x 10.16x
Debt to Equity 5.34x 1.20x 0.00x 0.00x 0.00x 0.00x 0.03x -- -- --
Revenue Growth (YoY) +627.8% -- -- -100.0% +9109.6% 0.0% 0.0% -28.0% +72.8% +94.6%
Operating Income Growth (YoY) -- -- -- -678.8% -- -- -- -- -- --
Net Income Growth (YoY) -- -- -- -699.1% -- -- -- -- -- --
EPS Growth (YoY) -- -- -- -612.5% -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -558.9% -- -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -- -560.9% -- -- -- -- -- --
5Y Revenue / Share Growth +5317.8% +455.9% -100.0% -100.0% +3115.6% -99.6% -- -- -- --
10Y Revenue / Share Growth -78.3% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -61.7% -77.0% -102.8% -158.2% -275.1% -433.7% -786.6% -1434.4%
Net Profit Margin -72.3% -87.5% -111.9% -165.4% -279.3% -428.5% -757.5% -1346.1%
Return on Equity (ROE) -- -1462.1% -584.4% -441.6% -269.9% -212.8% -154.0% -110.6%
Return on Assets (ROA) -30.2% -31.4% -51.5% -53.9% -56.5% -56.2% -51.7% -44.0%
Current Ratio 4.69x 6.77x 5.47x 4.40x 4.64x 4.71x 5.80x 5.82x
Quick Ratio 4.37x 6.44x 5.06x 4.12x 4.42x 4.55x 5.75x 5.82x
Debt to Equity -- 22.82x 8.28x 5.34x 2.98x 2.19x 1.60x 1.20x
Revenue Growth (YoY) +81.6% +91.8% +223.6% +794.9% +267.0% +984.5% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001395937) · from December 31, 2014 Data through September 30, 2026 · synced Nov 20, 2026, 05:31 UTC · Open in terminal